The 4th International Congress of AIFI – Italian Physiotherapy Association, entitled “What’s up: Moving Physiotherapy Science Forward. New Trajectories,” to analyze the approach to the complexity of physiotherapy for patient care was held in Florence, 22nd-24th November 2024.
The MerloBioEngineering team co-authored many presentations. We have already written about some of them in a previous post.
Parkinson and balance: the use of posturography
Dr. Chiara Bò, from the MerloBioEngineering team, presented the preliminary results of the work titled “Instrumental Static Balance Assessment of Patients with Parkinson’s Disease and Parkinsonism for Clinical Applications: a Systematic Review.”
The systematic review, currently waiting for publication, critically appraised the use of static posturography in patients with Parkinson’s disease, assessing the clinical, technical, and methodological aspects and identifying gaps hindering its translation into the clinical routine.
We aim to provide valuable and practical guidelines for clinicians who work daily with patients with Parkinson’s disease and researchers who publish papers about posturography.
The new MoRe scale: assessing patient mobility from bed to community
Dr. Maria Giulia Montecchi, from the Azienda USL-IRCCS of Reggio Emilia, presented the poster “Validity of the Mobility Recovery (MoRe) Scale for the Assessment of Patient Mobility from Bed to Community. A confirmatory Rasch analysis study”.
Starting in 2020, we began developing a new scale, the MoRe scale, that would allow the assessment of patients’ motor skills from hospitalization to outpatient settings, regardless of the disease. This would overcome the limitations of existing scales, which often suffer from ceiling or floor effect and can only assess a portion of the population.
The work required several years and the involvement of the entire Neuromotor and Rehabilitation Department of the Azienda of Reggio Emilia. Dr. Montecchi illustrated the confirmatory Rasch Analysis process using data from more than 1100 patients.
As the MerloBioEngineering team, we are proud to share our latest research and discuss innovations in motion analysis with the scientific community.
